To determine the effect of urologist and radiologist learning curves and changes in MRI-TRUS fusion platform during 9 years of NCI’s experience with multiparametric magnetic resonance imaging ...

Gemcitabine/cisplatin in patients with advanced bladder and impaired renal function: A retrospective analysis. Background: Multiple MRI techniques (T2W, dynamic contrast enhancement (DCE), ...

Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...

In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy. In men with prostate lesions visible on multiparametric magnetic resonance ...

STOCKHOLM — The first prospective trial comparing traditional transrectal ultrasound (TRUS)-guided biopsy with targeted MRI-guided biopsy for the triage of patients with suspected prostate cancer ...

Toronto - (February 4, 2021) The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) ...

Results from the phase 3 PRECISE trial showed that MRI with targeted biopsies matched or exceeded the accuracy of the current standard for detecting clinically significant prostate cancer. The current ...